Aicardi-Goutières syndrome (AGS)
Overview
Aicardi-Goutières syndrome (AGS) is a rare, inherited autoimmune and neurological disorder. It primarily affects the brain, immune system, and skin by causing the body to overproduce a chemical messenger called interferon. This triggers the immune system to attack the brain’s white matter, resulting in permanent damage.
Symptoms
Early-Onset (Congenital) AGS
Infants with early-onset AGS present at birth, often mimicking a congenital infection.Brain, liver, and spleen inflammation
Low platelet counts and bleeding issues (thrombocytopenia)Slower head growth leading to microcephaly (smaller head size)Seizures and trouble feeding
Rapid, involuntary twitching of the face and limbs
Later-Onset AGS
Most infants with AGS develop normally for their first few weeks or months of life before showing rapid neurological and physical regression.
Neurological & Motor: Extreme irritability, inconsolable crying, weak or stiffened muscles (spasticity), and involuntary muscle contractions (dystonia).
Dermatological: Chilblains—puffy, red, itchy, or blistered skin lesions on the toes, fingers, and ears that worsen in cold or wet weather.
Systemic: Intermittent, unexplained fevers not caused by an infection, and slowed head growth.
Developmental: Severe developmental delays, loss of acquired skills, and slowing of motor or speech abilities.
Causes
AGS is classified as a genetic disorder rather than a contagious disease or the result of environmental factors. The specific causes and inheritance patterns include:
Associated Genes: The syndrome is caused by variants in at least nine specific genes, most commonly TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR1.
Autosomal Recessive Inheritance: In most cases, the disease is inherited in an autosomal recessive manner. This means the affected child inherits two mutated copies of the gene—one from each parent. The parents are usually healthy carriers who do not show symptoms themselves.
Autosomal Dominant Inheritance: In rarer instances, the condition is passed on in an autosomal dominant pattern, requiring only one copy of the altered gene from a single parent.
De Novo Mutations: Sometimes, the genetic variants occur as a new mutation in the affected individual, meaning it was not inherited from either parent.
Diagnosis
Brain Imaging (MRI or CT): Neuroimaging is highly specific. An MRI or CT scan of the brain typically reveals basal ganglia calcifications (calcium deposits), leukodystrophy (white matter abnormalities), and cerebral atrophy.
Cerebrospinal Fluid (CSF) Analysis: A spinal tap is used to test for a chronic immune response in the brain. Doctors often find elevated white blood cells (pleiocytosis), elevated neopterin, and increased levels of interferon-alpha.
Blood Tests: Elevated levels of circulating liver enzymes, low platelet counts (thrombocytopenia), and a distinct "interferon signature" in the blood (elevated expression of interferon-stimulated genes) are strong indicators.
Genetic Testing: The ultimate confirmation requires genetic sequencing. Molecular testing looks for pathogenic variants in specific genes (e.g., TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, or IFIH1). This can be done via single-gene testing, multigene panels, or whole exome sequencing.
Treatment
Medical and Neurological Management
JAK Inhibitors: Drugs like baricitinib block the overactive type I interferon pathways that drive the disease, which can help patients reduce inflammation and achieve new developmental milestones.
Seizure Control: Antiseizure medications are tailored to individual needs if patients experience epilepsy.
Immunomodulation: Historic broad-acting immunosuppressive therapies, such as corticosteroids or intravenous immunoglobulin (IVIG), have been used with mixed or variable results to reduce inflammatory conditions.
Supportive Therapies
Respiratory Care: Physical therapy and devices may be required to clear the lungs and treat breathing complications.
Nutrition and Feeding: Patients experiencing feeding difficulties or severe nutritional deficits may require special diets or feeding tubes.
Developmental Services: Many benefit significantly from coordinated, ongoing physical, occupational, and speech therapies.
Type of DOctor Department : A pediatric neurologist
.jpg)
Comments
Post a Comment